B CELL LYMPHOMA

Clinical trials for B CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new B CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

New pill shows promise for Hard-to-Treat blood cancers

Disease control Completed

This study tested an oral drug called LOXO-305 (pirtobrutinib) in 803 people with chronic lymphocytic leukemia, small lymphocytic lymphoma, or other non-Hodgkin lymphomas whose cancer had stopped responding to or could not tolerate standard treatments. The goal was to find the be…

Matched conditions: B CELL LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control

Last updated Apr 29, 2026 05:16 UTC

B CELL LYMPHOMA

Get alerted when new B CELL LYMPHOMA trials appear

New pill shows promise for Hard-to-Treat blood cancers